Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13499-13509

  Robles, Maria Teresa Sáenz ^a   Shivalila, Chikdu ^a,b   Wano, Jeremy ^a,c   Sorrells, Shelly ^a,d   Roos, Alison ^a,e   Pipas, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; MESSENGER RNA; VIRUS LARGE T ANTIGEN; VIRUS T ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EMBRYO; HISTONE ACETYLATION; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POINT MUTATION; POLYOMA VIRUS; POLYSOME; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; SIMIAN VIRUS 40; STEADY STATE;

ACETYLATION; AMINO ACID MOTIFS; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CREB-BINDING PROTEIN; E1A-ASSOCIATED P300 PROTEIN; FIBROBLASTS; HISTONES; HUMANS; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 84888063943     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02658-13     Document Type: Article

References (77)

1. Ahuja D, Saenz-Robles MT, Pipas JM. 2005. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24:7729-7745.
2. Saenz Robles MT, Pipas JM. 2009. T antigen transgenic mouse models. Semin. Cancer Biol. 19:229-235.
3. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS. 2009. Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. Semin. Cancer Biol. 19:218-228.
4. Pipas JM. 2009. SV40:cell transformation and tumorigenesis. Virology 384:294-303.
5. Levine AJ. 2009. The common mechanisms of transformation by the small DNA tumor viruses:the inactivation of tumor suppressor gene products:p53. Virology 384:285-293.
6. DeCaprio JA. 2009. How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. Virology 384:274-284.
7. Ali SH, Kasper JS, Arai T, DeCaprio JA. 2004. Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 78:2749-2757.
8. Kasper JS, Kuwabara H, Arai T, Ali SH, DeCaprio JA. 2005. Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J. Virol. 79:11685-11692.
9. Cotsiki M, Lock RL, Cheng Y, Williams GL, Zhao J, Perera D, Freire R, Entwistle A, Golemis EA, Roberts TM, Jat PS, Gjoerup OV. 2004. Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc. Natl. Acad. Sci. U.S.A. 101:947-952.
10. Hein J, Boichuk S, Wu J, Cheng Y, Freire R, Jat PS, Roberts TM, Gjoerup OV. 2009. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83:117-127.
11. Welcker M, Clurman BE. 2005. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 280:7654-7658.
12. Sachsenmeier KF, Pipas JM. 2001. Inhibition of Rb and p53 is insufficient for SV40 T-antigen transformation. Virology 283:40-48.
13. Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA. 1996. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16:3454-3464.
14. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS. 1996. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J. 15:2236-2248.
15. Lill NL, Tevethia MJ, Eckner R, Livingston DM, Modjtahedi N. 1997. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71:129-137.
16. Hottiger MO, Nabel GJ. 2000. Viral replication and the coactivators p300 and CBP. Trends Microbiol. 8:560-565.
17. Smits PH, de Wit L, van der Eb AJ, Zantema A. 1996. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation. Oncogene 12:1529-1535.
18. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK. 2008. Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088.
19. Borger DR, DeCaprio JA. 2006. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J. Virol. 80:4292-4303.
20. Poulin DL, Kung AL, DeCaprio JA. 2004. p53 targets simian virus 40 large T antigen for acetylation by CBP. J. Virol. 78:8245-8253.
21. Patel D, Huang SM, Baglia LA, McCance DJ. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:5061-5072.
22. Bedford DC, Kasper LH, Fukuyama T, Brindle PK. 2010. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5:9-15.
23. Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
24. Partanen A, Motoyama J, Hui CC. 1999. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int. J. Dev. Biol. 43:487-494.
25. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
26. Oike Y, Takakura N, Hata A, Kaname T, Akizuki M, Yamaguchi Y, Yasue H, Araki K, Yamamura K, Suda T. 1999. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93:2771-2779.
27. Kung AL, Rebel VI, Bronson RT, Ch'ng LE, Sieff CA, Livingston DM, Yao TP. 2000. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:272-277.
28. Shikama N, Lutz W, Kretzschmar R, Sauter N, Roth JF, Marino S, Wittwer J, Scheidweiler A, Eckner R. 2003. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 22:5175-5185.
29. Ramos YF, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, van Galen M, van Dam H, van Ommen GJ, den Dunnen JT, Zantema A, t Hoen PA. 2010. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res. 38:5396-5408.
30. Roth JF, Shikama N, Henzen C, Desbaillets I, Lutz W, Marino S, Wittwer J, Schorle H, Gassmann M, Eckner R. 2003. Differential role of p300 and CBP acetyltransferase during myogenesis:p300 acts upstream of MyoD and Myf5. EMBO J. 22:5186-5196.
31. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM. 2002. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc. Natl. Acad. Sci. U.S.A. 99:14789-14794.
32. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM, Yokoyama KK. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284-289.
33. Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. 1999. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274:1189-1192.
34. Valls E, Blanco-Garcia N, Aquizu N, Piedra D, Estaras C, de la Cruz X, Martinez-Balbas MA. 2007. Involvement of chromatin and histone deacetylation in SV40 T antigen transcription regulation. Nucleic Acids Res. 35:1958-1968.
35. Valls E, de la Cruz X, Martinez-Balbas MA. 2003. The SV40 T antigen modulates CBP histone acetyltransferase activity. Nucleic Acids Res. 31:3114-3122.
36. Markovics JA, Carroll PA, Robles MT, Pope H, Coopersmith CM, Pipas JM. 2005. Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. J. Virol. 79:7492-7502.
37. Rathi AV, Cantalupo PG, Sarkar SN, Pipas JM. 2010. Induction of interferon-stimulated genes by Simian virus 40 T antigens. Virology 406:202-211.
38. Ahuja D, Rathi AV, Greer AE, Chen XS, Pipas JM. 2009. A structureguided mutational analysis of simian virus 40 large T antigen:identification of surface residues required for viral replication and transformation. J. Virol. 83:8781-8788.
39. Harlow E, Crawford LV, Pim DC, Williamson NM. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861-869.
40. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ. 2008. Adenovirus small e1a alters global patterns of histone modification. Science 321:1084-1085.
41. Gamalinda M, Jakovljevic J, Babiano R, Talkish J, de la Cruz J, Woolford JL, Jr. 2013. Yeast polypeptide exit tunnel ribosomal proteins L17, L35 and L37 are necessary to recruit late-assembling factors required for 27SB pre-rRNA processing. Nucleic Acids Res. 41:1965-1983.
42. Saenz-Robles MT, Toma D, Cantalupo P, Zhou J, Gong H, Edwards C, Pipas JM, Xie W. 2007. Repression of intestinal drug metabolizing enzymes by the SV40 large T antigen. Oncogene 26:5124-5131.
43. Chan HM, La Thangue NB. 2001. p300/CBP proteins:HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
44. Yuan LW, Giordano A. 2002. Acetyltransferase machinery conserved in p300/CBP-family proteins. Oncogene 21:2253-2260.
45. Galbiati L, Mendoza-Maldonado R, Gutierrez MI, Giacca M. 2005. Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination. Cell Cycle 4:930-939.
46. Levy L, Wei Y, Labalette C, Wu Y, Renard CA, Buendia MA, Neuveut C. 2004. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 24:3404-3414.
47. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB. 2001. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat. Cell Biol. 3:667-674.
48. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, Giacca M. 2000. E2F family members are differentially regulated by reversible acetylation. J. Biol. Chem. 275:10887-10892.
49. McManus KJ, Hendzel MJ. 2003. Quantitative analysis of CBP-and P300-induced histone acetylations in vivo using native chromatin. Mol. Cell. Biol. 23:7611-7627.
50. Thompson PR, Wang D, Wang L, Fulco M, Pediconi N, Zhang D, An W, Ge Q, Roeder RG, Wong J, Levrero M, Sartorelli V, Cotter RJ, Cole PA. 2004. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 11:308-315.
51. Ogiwara H, Kohno T. 2012. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes. PLoS One 7:e52810. doi:10.1371/journal.pone.0052810.
52. Kalkhoven E. 2004. CBP and p300:HATs for different occasions. Biochem. Pharmacol. 68:1145-1155.
53. Cantalupo PG, Saenz-Robles MT, Rathi AV, Beerman RW, Patterson WH, Whitehead RH, Pipas JM. 2009. Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology 386:183-191.
54. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
55. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643.
56. Martinez-Balbas MA, Bannister AJ, Martin K, Haus-Seuffert P, Meisterernst M, Kouzarides T. 1998. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17:2886-2893.
57. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C. 2000. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24:300-303.
58. Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, Buetow KH, Pui CH, Baker SD, Brindle PK, Downing JR. 2011. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471:235-239.
59. Dai P, Akimaru H, Tanaka Y, Hou DX, Yasukawa T, Kanei-Ishii C, Takahashi T, Ishii S. 1996. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10:528-540.
60. Trouche D, Cook A, Kouzarides T. 1996. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24:4139-4145.
61. Trouche D, Kouzarides T. 1996. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc. Natl. Acad. Sci. U.S.A. 93:1439-1442.
62. Wang L, Grossman SR, Kieff E. 2000. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl. Acad. Sci. U.S.A. 97:430-435.
63. Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F. 2000. Acetylation of HIV-1 Tat by CBP/ P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277:278-295.
64. Pelka P, Ablack JN, Torchia J, Turnell AS, Grand RJ, Mymryk JS. 2009. Transcriptional control by adenovirus E1A conserved region 3 via p300/ CBP. Nucleic Acids Res. 37:1095-1106.
65. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81-84.
66. Yaciuk P, Carter MC, Pipas JM, Moran E. 1991. Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol. Cell. Biol. 11:2116-2124.
67. Beachy TM, Cole SL, Cavender JF, Tevethia MJ. 2002. Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts. J. Virol. 76:3145-3157.
68. Vempati RK, Jayani RS, Notani D, Sengupta A, Galande S, Haldar D. 2010. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J. Biol. Chem. 285:28553-28564.
69. Das C, Lucia MS, Hansen KC, Tyler JK. 2009. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:113-117.
70. Chang CS, Pillus L. 2009. Collaboration between the essential Esa1 acetyltransferase and the Rpd3 deacetylase is mediated by H4K12 histone acetylation in Saccharomyces cerevisiae. Genetics 183:149-160.
71. Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD. 1995. Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc. Natl. Acad. Sci. U.S.A. 92:1237-1241.
72. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, Cota P, Wittnam JL, Gogol-Doering A, Opitz L, Salinas-Riester G, Dettenhofer M, Kang H, Farinelli L, Chen W, Fischer A. 2010. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753-756.
73. Akiyama T, Kim JM, Nagata M, Aoki F. 2004. Regulation of histone acetylation during meiotic maturation in mouse oocytes. Mol. Reprod. Dev. 69:222-227.
74. Manosalva I, Gonzalez A. 2009. Aging alters histone H4 acetylation and CDC2A in mouse germinal vesicle stage oocytes. Biol. Reprod. 81:1164-1171.
75. LeRoy G, Rickards B, Flint SJ. 2008. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30:51-60.
76. Masumoto H, Hawke D, Kobayashi R, Verreault A. 2005. A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 436:294-298.
77. Kim HY, Ahn BY, Cho Y. 2001. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 20:295-304.